Financials

  • Market Capitalization 3.66 B
  • Employee 192
  • Founded 2015
  • CEO N/A
  • Website www.relaytx.com
  • Headquarter Delaware, United States
  • FIGI BBG00DSS08K9
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.38
ratio cours/chiffre d'affaires
161.99

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
1534
CPRX
Catalyst Pharmaceuticals, Inc. - Common Stock
31.49 USD+0.03%+0.06%+0.41%+48.47%3.85 B USD
1554
TLX
Telix Pharmaceuticals Limited - American Depositary Shares
11.02 USD+0.46%-4.09%+14.20%+74.64%3.73 B USD
1576
GPCR
Structure Therapeutics Inc - American Depositary Shares
50.59 USD-2.03%-10.21%+18.45%+89.19%3.60 B USD
1577
DNLI
Denali Therapeutics Inc. - Common Stock
22.65 USD-14.46%-13.15%+2.40%+40.07%3.59 B USD

Nouvelles